NOVABAY PHARMACEUTICALS INC (NBY)
US66987P4090 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to NBY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.8. This target is 617.02% above the current price.
NBY was analyzed by 6 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NBY.
In the previous month the buy percentage consensus was at a similar level.
NBY was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-11 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-08-11 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2022-05-20 | Ascendiant Capital | Maintains | Buy |